Name

Mirabegron

Description

Mirabegron is a beta-3 adrenergic receptor agonist for the management of overactive bladder. It is an alternative to antimuscarinic drugs for this indication. FDA approved on June 28, 2012.

Brands

Company not known

Betanis

Company not known

Metmiga